Panacea Biotec Ltd receives acceptance from CMSS for supply of bOPV

The Central Medical Services Society, Ministry of Health and Family Welfare, Government of India ("CMSS") has, vide its Letter of Acceptance ("LOA") dated October 08, 2025, accepted the Panacea Biotec Limited's offer for supply of bivalent oral polio vaccine (bOPV) against the tender issued by it in this regard.

As per the LOA, the Company will supply the vaccine worth Rs.127.20 Crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA.

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 431.25 as compared to the previous close of Rs. 431.40. The total number of shares traded during the day was 8951 in over 452 trades.

The stock hit an intraday high of Rs. 447.60 and intraday low of 429.65. The net turnover during the day was Rs. 3940066.00.

Source : Equity Bulls

Keywords

PanaceaBiotec INE922B01023 Biotechnology bOPV CMSS Supply